ascorbic acid 7540 MG / polyethylene glycol 3350 40000 MG / potassium chloride 1200 MG / sodium ascorbate 48110 MG / sodium chloride 3200 MG Powder for Oral Solution
- RxCUI
- 2045243
- RxNorm name
- ascorbic acid 7540 MG / polyethylene glycol 3350 40000 MG / potassium chloride 1200 MG / sodium ascorbate 48110 MG / sodium chloride 3200 MG Powder for Oral Solution
- Display name
- Ascorbic acid/Polyethylene glycol 3350/Potassium chloride/Sodium ascorbate/Sodium chloride (Oral Solution Powder)
- Full name
- ascorbic acid 7540 MG / polyethylene glycol 3350 40000 MG / potassium chloride 1200 MG / sodium ascorbate 48110 MG / sodium chloride 3200 MG Powder for Oral Solution
- Term type
- SCD
- Status
- Active
- Strength
- 7,540-40,000-1,200-48,110-3,200 mg
- Dose form
- Pwdr
- Route
- Oral Solution Powder
- Updated
- 2026-11-06 11:40:35
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 062018
- Active start
- 062018
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| ascorbic acid | 7540 MG / 1 EACH | ascorbic acid | ascorbic acid |
| polyethylene glycol 3350 | 40000 MG / 1 EACH | polyethylene glycol 3350 | polyethylene glycol 3350 |
| sodium ascorbate | 48110 MG / 1 EACH | sodium ascorbate | sodium ascorbate |
| potassium chloride | 1200 MG / 1 EACH | potassium chloride | potassium chloride |
| sodium chloride | 3200 MG / 1 EACH | sodium chloride | sodium chloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Powder for Oral Solution | 1540455 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| ascorbic acid | 1151 |
| polyethylene glycol 3350 | 221147 |
| sodium ascorbate | 267366 |
| potassium chloride | 8591 |
| sodium chloride | 9863 |
Source Vocabulary Codes#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Plenvu | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE | Salix Pharmaceuticals, Inc | 79f930fa-5674-4f30-8ae8-9448d6243797 | 2023-09-01 | Warnings, Adverse reactions | 2045243 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 79f930fa-5674-4f30-8ae8-9448d6243797 | ascorbic acid 7540 MG / polyethylene glycol 3350 40000 MG / potassium chloride 1200 MG / sodium ascorbate 48110 MG / sodium chloride 3200 MG Powder for Oral Solution [SCD] · vit-C 7540 MG / POLYETHYLENE GLYCOL 3350 40000 MG / K+ Chloride 1200 MG / Sodium Ascorbate 48110 MG / NaCl 3200 MG Powder for Oral Solution [SY] · vit-C 7540 MG / POLYETHYLENE GLYCOL 3350 40000 MG / Pot Chloride 1200 MG / Sodium Ascorbate 48110 MG / NaCl 3200 MG Powder for Oral Solution [SY] · vitamin C 7540 MG / POLYETHYLENE GLYCOL 3350 40000 MG / K+ Chloride 1200 MG / Sodium Ascorbate 48110 MG / NaCl 3200 MG Powder for Oral Solution [SY] · vitamin C 7540 MG / POLYETHYLENE GLYCOL 3350 40000 MG / Pot Chloride 1200 MG / Sodium Ascorbate 48110 MG / NaCl 3200 MG Powder for Oral Solution [SY] | 5 | 12 | These highlights do not include all the information needed to use PLENVU safely and effectively. See full prescribing information for PLENVU. PLENVU ® (polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride for oral solution) Initial U.S. Approval: 2006 | 20230901 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A11GA | Ascorbic acid (vitamin C), plain | ATC1-4 | ascorbic acid | |
| ATC | B05XA | Electrolyte solutions | ATC1-4 | potassium chloride | |
| ATC | B05XA | Electrolyte solutions | ATC1-4 | sodium chloride | |
| ATC | G01AD | Organic acids | ATC1-4 | ascorbic acid | |
| ATC | S01XA | Other ophthalmologicals | ATC1-4 | ascorbic acid | |
| ATC | A12BA | Potassium | ATC1-4 | potassium chloride | |
| ATC | B05CB | Salt solutions | ATC1-4 | sodium chloride | |
| ATC | A12CA | Sodium | ATC1-4 | sodium chloride | |
| FDASPL | D001205 | Ascorbic Acid | CHEM | has_chemical_structure | ascorbic acid |
| FDASPL | N0000175811 | Osmotic Laxative | EPC | has_epc | polyethylene glycol 3350 |
| FDASPL | N0000193618 | Vitamin C | EPC | has_epc | ascorbic acid |
| FDASPL | N0000010288 | Osmotic Activity | MOA | has_moa | polyethylene glycol 3350 |
| FDASPL | N0000009871 | Stimulation Large Intestine Fluid/Electrolyte Secretion | PE | has_pe | polyethylene glycol 3350 |
| MEDRT | D001205 | Ascorbic Acid | CHEM | has_ingredient | ascorbic acid |
| MEDRT | D001205 | Ascorbic Acid | CHEM | has_ingredient | sodium ascorbate |
| MEDRT | D011092 | Polyethylene Glycols | CHEM | has_ingredient | polyethylene glycol 3350 |
| MEDRT | D011189 | Potassium Chloride | CHEM | has_ingredient | potassium chloride |
| MEDRT | D012965 | Sodium Chloride | CHEM | has_ingredient | sodium chloride |
| MEDRT | D000224 | Addison Disease | DISEASE | ci_with | potassium chloride |
| MEDRT | D000471 | Alkalosis | DISEASE | ci_with | sodium chloride |
| MEDRT | D000740 | Anemia | DISEASE | may_treat | sodium ascorbate |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | sodium ascorbate |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | ascorbic acid |
| MEDRT | D003248 | Constipation | DISEASE | may_treat | polyethylene glycol 3350 |
| MEDRT | D015715 | Corneal Edema | DISEASE | may_treat | sodium chloride |
| MEDRT | D003681 | Dehydration | DISEASE | may_prevent | sodium chloride |
| MEDRT | D003681 | Dehydration | DISEASE | ci_with | potassium chloride |
| MEDRT | D003681 | Dehydration | DISEASE | may_treat | sodium chloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | potassium chloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | polyethylene glycol 3350 |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | sodium ascorbate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ascorbic acid |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | sodium chloride |
| MEDRT | D015352 | Dry Eye Syndromes | DISEASE | may_treat | sodium chloride |
| MEDRT | D004487 | Edema | DISEASE | ci_with | sodium chloride |
| MEDRT | D018589 | Gastroparesis | DISEASE | ci_with | polyethylene glycol 3350 |
| MEDRT | D006947 | Hyperkalemia | DISEASE | ci_with | potassium chloride |
| MEDRT | D006955 | Hypernatremia | DISEASE | ci_with | sodium chloride |
| MEDRT | D006959 | Hyperoxaluria | DISEASE | induces | ascorbic acid |
| MEDRT | D006959 | Hyperoxaluria | DISEASE | induces | sodium ascorbate |
| MEDRT | D007008 | Hypokalemia | DISEASE | may_prevent | potassium chloride |
| MEDRT | D007008 | Hypokalemia | DISEASE | may_treat | potassium chloride |
| MEDRT | D007010 | Hyponatremia | DISEASE | may_treat | sodium chloride |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | potassium chloride |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | polyethylene glycol 3350 |
| MEDRT | D007416 | Intestinal Perforation | DISEASE | ci_with | polyethylene glycol 3350 |
| MEDRT | D008532 | Megacolon, Toxic | DISEASE | ci_with | polyethylene glycol 3350 |
| MEDRT | D008708 | Methemoglobinemia | DISEASE | may_treat | sodium ascorbate |
| MEDRT | D008708 | Methemoglobinemia | DISEASE | may_treat | ascorbic acid |
| MEDRT | D020513 | Paralysis, Hyperkalemic Periodic | DISEASE | ci_with | potassium chloride |
| MEDRT | D011654 | Pulmonary Edema | DISEASE | ci_with | sodium chloride |
| MEDRT | D051437 | Renal Insufficiency | DISEASE | ci_with | potassium chloride |
| MEDRT | D012614 | Scurvy | DISEASE | may_treat | sodium ascorbate |
| MEDRT | D012614 | Scurvy | DISEASE | may_treat | ascorbic acid |
| MEDRT | D012771 | Shock, Hemorrhagic | DISEASE | may_treat | sodium chloride |
| MEDRT | D020176 | Tyrosinemias | DISEASE | may_treat | sodium ascorbate |
| MEDRT | D020176 | Tyrosinemias | DISEASE | may_treat | ascorbic acid |
| MEDRT | D014947 | Wounds and Injuries | DISEASE | may_treat | sodium chloride |
| MEDRT | D014950 | Wounds, Penetrating | DISEASE | may_treat | ascorbic acid |
| MEDRT | D014950 | Wounds, Penetrating | DISEASE | may_treat | sodium ascorbate |
| MEDRT | N0000000226 | Acid-Base Activity | MOA | has_moa | potassium chloride |
| MEDRT | N0000000226 | Acid-Base Activity | MOA | has_moa | sodium chloride |
| MEDRT | N0000000220 | Electrolyte Activity | MOA | has_moa | sodium chloride |
| MEDRT | N0000000220 | Electrolyte Activity | MOA | has_moa | potassium chloride |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | ascorbic acid |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | sodium ascorbate |
| MEDRT | N0000000170 | Free Radical Scavenging Activity | MOA | has_moa | sodium ascorbate |
| MEDRT | N0000000170 | Free Radical Scavenging Activity | MOA | has_moa | ascorbic acid |
| MEDRT | N0000010288 | Osmotic Activity | MOA | has_moa | polyethylene glycol 3350 |
| MEDRT | N0000009915 | Unknown Cellular or Molecular Interaction | MOA | has_moa | polyethylene glycol 3350 |
| MEDRT | N0000008294 | Alveolar Surface Tension Reduction | PE | has_pe | sodium chloride |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | potassium chloride |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | sodium ascorbate |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | ascorbic acid |
| MEDRT | N0000008867 | Decreased Respiratory Secretion Viscosity | PE | has_pe | sodium chloride |
| MEDRT | N0000009360 | Increased Insulin Secretion | PE | has_pe | potassium chloride |
| MEDRT | N0000009361 | Increased Intravascular Volume | PE | has_pe | sodium chloride |
| MEDRT | N0000009726 | Inhibition Large Intestine Fluid/Electrolyte Absorption | PE | has_pe | polyethylene glycol 3350 |
| MEDRT | N0000009774 | Organized Electrical Activity Alteration | PE | has_pe | potassium chloride |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 7540 MG / 40000 MG / 1200 MG / 48110 MG / 3200 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |